Intraarterial infusion chemotherapy in regionally advanced malignant melanoma

1990 ◽  
Vol 43 (4) ◽  
pp. 239-244 ◽  
Author(s):  
Annamaria Calabro ◽  
S. Eva Singletary ◽  
Cesar H. Carrasco ◽  
Sewa S. Legha
Keyword(s):  
Malignant Melanoma ◽  
Intraarterial Infusion ◽  
Infusion Chemotherapy ◽  
Advanced Malignant Melanoma

Evaluations of Combination Chemotherapy(DAC-Tam) for Advanced Malignant Melanoma. Possible Patient Groups which may Show a Good Response Rate.

2001 ◽  
Vol 63 (5) ◽  
pp. 561-568
Author(s):  
Hideki KAMIYA ◽  
Hiroyuki KANOH ◽  
Naoki ICHIHASHI ◽  
Yoshiro ICHIKI ◽  
Hajime TAKAGI ◽  
...  
Keyword(s):  
Malignant Melanoma ◽  
Combination Chemotherapy ◽  
Response Rate ◽  
Good Response Rate ◽  
Advanced Malignant Melanoma ◽  
Patient Groups

scholarly journals Regulatory T-Cell–Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant Melanoma

2009 ◽  
Vol 15 (6) ◽  
pp. 2166-2173 ◽  
Author(s):  
Theo Nicholaou ◽  
Lisa M. Ebert ◽  
Ian D. Davis ◽  
Grant A. McArthur ◽  
Heather Jackson ◽  
...  
Keyword(s):  
T Cell ◽  
Malignant Melanoma ◽  
Regulatory T Cell ◽  
T Cell Responses ◽  
Cell Responses ◽  
Advanced Malignant Melanoma

scholarly journals A Prospective Study of Intraarterial Infusion Chemotherapy in Advanced WT BRAF Melanoma Patients

2021 ◽  
Author(s):  
Stefano Guadagni ◽  
Odysseas Zoras ◽  
Giammaria Fiorentini ◽  
Francesco Masedu ◽  
Konstantinos Lasithiotakis ◽  
...  
Keyword(s):  
Prospective Study ◽  
Intraarterial Infusion ◽  
Infusion Chemotherapy ◽  
Melanoma Patients ◽  
A Prospective Study ◽  
Braf Melanoma

Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma

2009 ◽  
Vol 19 (3) ◽  
pp. 185-192 ◽  
Author(s):  
Tim Eisen ◽  
José Thomas ◽  
Wilson H. Miller ◽  
Martin Gore ◽  
Pascal Wolter ◽  
...  
Keyword(s):  
Malignant Melanoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy ◽  
Advanced Malignant Melanoma

Effective eradication of oral verrucous carcinoma with continuous intraarterial infusion chemotherapy

Head & Neck ◽  
2008 ◽  
Vol 30 (5) ◽  
pp. 611-617 ◽  
Author(s):  
Chih-Fung Wu ◽  
Chung-Ming Chen ◽  
Yee-Shyong Shen ◽  
I-Yueh Huang ◽  
Chung-Ho Chen ◽  
...  
Keyword(s):  
Verrucous Carcinoma ◽  
Intraarterial Infusion ◽  
Infusion Chemotherapy

scholarly journals Dinitrophenyl hapten with laser immunotherapy for advanced malignant melanoma: A clinical study

2016 ◽  
Vol 13 (3) ◽  
pp. 1425-1431 ◽  
Author(s):  
Dian-Jun Chen ◽  
Xiao-Song Li ◽  
Hui Zhao ◽  
Yan Fu ◽  
Huan-Rong Kang ◽  
...  
Keyword(s):  
Clinical Study ◽  
Malignant Melanoma ◽  
Advanced Malignant Melanoma ◽  
Laser Immunotherapy

Active outpatient, three drugs Fotemustine (FTMU), Dacarbarzine (DTIC), Vindestine (VDS)) combination in advanced malignant melanoma (MM)

1993 ◽  
Vol 3 (1) ◽  
pp. 36
Author(s):  
C H. Borel ◽  
E. Vuillemin ◽  
A. Benhammouda ◽  
M. Weil ◽  
G. Auclerc ◽  
...  
Keyword(s):  
Malignant Melanoma ◽  
Advanced Malignant Melanoma

scholarly journals A Phase I Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma

2015 ◽  
Vol 20 (6) ◽  
pp. 617-618 ◽  
Author(s):  
Ryan J. Sullivan ◽  
Nageatte Ibrahim ◽  
Donald P. Lawrence ◽  
Julie Aldridge ◽  
Anita Giobbie‐Hurder ◽  
...  
Keyword(s):  
Malignant Melanoma ◽  
Phase I ◽  
Phase I Trial ◽  
Advanced Malignant Melanoma

Results of a phase II trial with cystemustine at 90 mg/m2 as a first-or second-line treatment in advanced malignant melanoma

1999 ◽  
Vol 9 (6) ◽  
pp. 607-610 ◽  
Author(s):  
H. Cure ◽  
P. Souteyrand ◽  
R. Ouabdesselam ◽  
H. Roche ◽  
A. Ravaud ◽  
...  
Keyword(s):  
Malignant Melanoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Line Treatment ◽  
Second Line ◽  
Advanced Malignant Melanoma
Sign in / Sign up

Export Citation Format

Share Document